nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP1A2—Dacarbazine—muscle cancer	0.0846	0.328	CbGbCtD
Mianserin—CYP2B6—Doxorubicin—muscle cancer	0.0482	0.187	CbGbCtD
Mianserin—CYP1A2—Etoposide—muscle cancer	0.0414	0.161	CbGbCtD
Mianserin—CYP3A4—Vincristine—muscle cancer	0.0237	0.0919	CbGbCtD
Mianserin—CYP2D6—Doxorubicin—muscle cancer	0.0233	0.0903	CbGbCtD
Mianserin—CYP3A4—Etoposide—muscle cancer	0.0217	0.0842	CbGbCtD
Mianserin—Bone marrow depression—Vincristine—muscle cancer	0.015	0.0288	CcSEcCtD
Mianserin—CYP3A4—Doxorubicin—muscle cancer	0.0148	0.0574	CbGbCtD
Mianserin—HRH4—bone marrow—muscle cancer	0.0147	0.0661	CbGeAlD
Mianserin—HTR2A—hindlimb—muscle cancer	0.012	0.054	CbGeAlD
Mianserin—HTR2A—appendage—muscle cancer	0.0103	0.0463	CbGeAlD
Mianserin—HTR1F—head—muscle cancer	0.00877	0.0395	CbGeAlD
Mianserin—Lethargy—Dactinomycin—muscle cancer	0.00837	0.0161	CcSEcCtD
Mianserin—HRH2—cardiac atrium—muscle cancer	0.00729	0.0329	CbGeAlD
Mianserin—Bone marrow depression—Methotrexate—muscle cancer	0.00726	0.014	CcSEcCtD
Mianserin—Cardiac arrest—Vincristine—muscle cancer	0.00697	0.0134	CcSEcCtD
Mianserin—Pancytopenia—Dactinomycin—muscle cancer	0.00674	0.0129	CcSEcCtD
Mianserin—Neutropenia—Dactinomycin—muscle cancer	0.00663	0.0127	CcSEcCtD
Mianserin—Bone marrow depression—Doxorubicin—muscle cancer	0.00629	0.0121	CcSEcCtD
Mianserin—DRD3—head—muscle cancer	0.00619	0.0279	CbGeAlD
Mianserin—Cardiac failure—Etoposide—muscle cancer	0.00609	0.0117	CcSEcCtD
Mianserin—Pancytopenia—Vincristine—muscle cancer	0.00602	0.0116	CcSEcCtD
Mianserin—HTR6—head—muscle cancer	0.00596	0.0269	CbGeAlD
Mianserin—Neutropenia—Vincristine—muscle cancer	0.00593	0.0114	CcSEcCtD
Mianserin—Agranulocytosis—Dactinomycin—muscle cancer	0.0059	0.0113	CcSEcCtD
Mianserin—Erectile dysfunction—Vincristine—muscle cancer	0.00584	0.0112	CcSEcCtD
Mianserin—Hepatitis—Dactinomycin—muscle cancer	0.00568	0.0109	CcSEcCtD
Mianserin—Cardiac arrest—Etoposide—muscle cancer	0.00565	0.0109	CcSEcCtD
Mianserin—OPRK1—head—muscle cancer	0.00552	0.0249	CbGeAlD
Mianserin—HRH2—head—muscle cancer	0.00545	0.0246	CbGeAlD
Mianserin—Hepatic enzyme increased—Methotrexate—muscle cancer	0.00518	0.00996	CcSEcCtD
Mianserin—Blood disorder—Doxorubicin—muscle cancer	0.00508	0.00976	CcSEcCtD
Mianserin—HTR2B—smooth muscle tissue—muscle cancer	0.00502	0.0226	CbGeAlD
Mianserin—Connective tissue disorder—Vincristine—muscle cancer	0.00498	0.00958	CcSEcCtD
Mianserin—Pancytopenia—Etoposide—muscle cancer	0.00488	0.00937	CcSEcCtD
Mianserin—Neutropenia—Etoposide—muscle cancer	0.0048	0.00923	CcSEcCtD
Mianserin—Cardiac disorder—Vincristine—muscle cancer	0.00471	0.00905	CcSEcCtD
Mianserin—Angiopathy—Vincristine—muscle cancer	0.0046	0.00884	CcSEcCtD
Mianserin—Mediastinal disorder—Vincristine—muscle cancer	0.00457	0.00879	CcSEcCtD
Mianserin—Anaemia—Dactinomycin—muscle cancer	0.00457	0.00878	CcSEcCtD
Mianserin—Jaundice—Etoposide—muscle cancer	0.00446	0.00857	CcSEcCtD
Mianserin—Mental disorder—Vincristine—muscle cancer	0.00444	0.00854	CcSEcCtD
Mianserin—Leukopenia—Dactinomycin—muscle cancer	0.00442	0.0085	CcSEcCtD
Mianserin—Gynaecomastia—Methotrexate—muscle cancer	0.00439	0.00843	CcSEcCtD
Mianserin—HTR1A—renal system—muscle cancer	0.00433	0.0195	CbGeAlD
Mianserin—Hepatobiliary disease—Etoposide—muscle cancer	0.00433	0.00832	CcSEcCtD
Mianserin—HTR7—smooth muscle tissue—muscle cancer	0.0043	0.0194	CbGeAlD
Mianserin—Agranulocytosis—Etoposide—muscle cancer	0.00427	0.00821	CcSEcCtD
Mianserin—Myalgia—Dactinomycin—muscle cancer	0.00421	0.00809	CcSEcCtD
Mianserin—HTR7—renal system—muscle cancer	0.00414	0.0187	CbGeAlD
Mianserin—Anaemia—Vincristine—muscle cancer	0.00408	0.00784	CcSEcCtD
Mianserin—Agitation—Vincristine—muscle cancer	0.00406	0.0078	CcSEcCtD
Mianserin—Oedema—Dactinomycin—muscle cancer	0.00403	0.00775	CcSEcCtD
Mianserin—Vertigo—Vincristine—muscle cancer	0.00397	0.00762	CcSEcCtD
Mianserin—Leukopenia—Vincristine—muscle cancer	0.00395	0.0076	CcSEcCtD
Mianserin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00395	0.00759	CcSEcCtD
Mianserin—Eye disorder—Etoposide—muscle cancer	0.00384	0.00738	CcSEcCtD
Mianserin—Convulsion—Vincristine—muscle cancer	0.00383	0.00735	CcSEcCtD
Mianserin—Cardiac disorder—Etoposide—muscle cancer	0.00381	0.00733	CcSEcCtD
Mianserin—Hypertension—Vincristine—muscle cancer	0.00381	0.00733	CcSEcCtD
Mianserin—ADRA2C—renal system—muscle cancer	0.00381	0.0172	CbGeAlD
Mianserin—HTR2B—tendon—muscle cancer	0.00377	0.017	CbGeAlD
Mianserin—Myalgia—Vincristine—muscle cancer	0.00376	0.00722	CcSEcCtD
Mianserin—Angiopathy—Etoposide—muscle cancer	0.00373	0.00716	CcSEcCtD
Mianserin—Mediastinal disorder—Etoposide—muscle cancer	0.0037	0.00712	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00367	0.00706	CcSEcCtD
Mianserin—Lethargy—Methotrexate—muscle cancer	0.00363	0.00698	CcSEcCtD
Mianserin—Oedema—Vincristine—muscle cancer	0.0036	0.00693	CcSEcCtD
Mianserin—SLC6A3—head—muscle cancer	0.00356	0.0161	CbGeAlD
Mianserin—Nervous system disorder—Vincristine—muscle cancer	0.00353	0.00679	CcSEcCtD
Mianserin—Thrombocytopenia—Vincristine—muscle cancer	0.00353	0.00678	CcSEcCtD
Mianserin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00353	0.00677	CcSEcCtD
Mianserin—HTR2B—vagina—muscle cancer	0.0035	0.0158	CbGeAlD
Mianserin—HTR1D—head—muscle cancer	0.00348	0.0157	CbGeAlD
Mianserin—Fatigue—Dactinomycin—muscle cancer	0.00348	0.00668	CcSEcCtD
Mianserin—HTR2C—head—muscle cancer	0.00344	0.0155	CbGeAlD
Mianserin—SLC6A3—testis—muscle cancer	0.00344	0.0155	CbGeAlD
Mianserin—HTR2A—embryo—muscle cancer	0.00341	0.0154	CbGeAlD
Mianserin—ADRA2C—cardiac atrium—muscle cancer	0.00341	0.0154	CbGeAlD
Mianserin—Hypotension—Vincristine—muscle cancer	0.00337	0.00647	CcSEcCtD
Mianserin—Feeling abnormal—Dactinomycin—muscle cancer	0.00332	0.00639	CcSEcCtD
Mianserin—Anaemia—Etoposide—muscle cancer	0.00331	0.00635	CcSEcCtD
Mianserin—CYP1A2—renal system—muscle cancer	0.0033	0.0149	CbGeAlD
Mianserin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00328	0.00631	CcSEcCtD
Mianserin—SLC6A4—head—muscle cancer	0.00327	0.0147	CbGeAlD
Mianserin—Paraesthesia—Vincristine—muscle cancer	0.00324	0.00622	CcSEcCtD
Mianserin—HTR2B—head—muscle cancer	0.00324	0.0146	CbGeAlD
Mianserin—HTR7—tendon—muscle cancer	0.00323	0.0146	CbGeAlD
Mianserin—Breast disorder—Methotrexate—muscle cancer	0.00322	0.00618	CcSEcCtD
Mianserin—Vertigo—Etoposide—muscle cancer	0.00321	0.00618	CcSEcCtD
Mianserin—HRH1—smooth muscle tissue—muscle cancer	0.00321	0.0145	CbGeAlD
Mianserin—Leukopenia—Etoposide—muscle cancer	0.0032	0.00615	CcSEcCtD
Mianserin—CYP2B6—renal system—muscle cancer	0.00317	0.0143	CbGeAlD
Mianserin—Cardiac failure—Doxorubicin—muscle cancer	0.00316	0.00607	CcSEcCtD
Mianserin—Loss of consciousness—Etoposide—muscle cancer	0.00314	0.00604	CcSEcCtD
Mianserin—Lethargy—Doxorubicin—muscle cancer	0.00314	0.00604	CcSEcCtD
Mianserin—Gastrointestinal disorder—Vincristine—muscle cancer	0.00311	0.00598	CcSEcCtD
Mianserin—Fatigue—Vincristine—muscle cancer	0.00311	0.00597	CcSEcCtD
Mianserin—Convulsion—Etoposide—muscle cancer	0.0031	0.00596	CcSEcCtD
Mianserin—Hypertension—Etoposide—muscle cancer	0.00309	0.00593	CcSEcCtD
Mianserin—Constipation—Vincristine—muscle cancer	0.00308	0.00592	CcSEcCtD
Mianserin—Diplopia—Doxorubicin—muscle cancer	0.00308	0.00592	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00302	0.00581	CcSEcCtD
Mianserin—ADRA2C—tendon—muscle cancer	0.00297	0.0134	CbGeAlD
Mianserin—Confusional state—Etoposide—muscle cancer	0.00294	0.00566	CcSEcCtD
Mianserin—Cardiac arrest—Doxorubicin—muscle cancer	0.00293	0.00563	CcSEcCtD
Mianserin—Pancytopenia—Methotrexate—muscle cancer	0.00292	0.00561	CcSEcCtD
Mianserin—HTR1A—head—muscle cancer	0.0029	0.0131	CbGeAlD
Mianserin—Asthenia—Dactinomycin—muscle cancer	0.00289	0.00556	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—muscle cancer	0.00288	0.00553	CcSEcCtD
Mianserin—SLC6A2—head—muscle cancer	0.00287	0.013	CbGeAlD
Mianserin—Thrombocytopenia—Etoposide—muscle cancer	0.00286	0.00549	CcSEcCtD
Mianserin—Tachycardia—Etoposide—muscle cancer	0.00285	0.00548	CcSEcCtD
Mianserin—Skin disorder—Etoposide—muscle cancer	0.00284	0.00545	CcSEcCtD
Mianserin—Erectile dysfunction—Methotrexate—muscle cancer	0.00283	0.00544	CcSEcCtD
Mianserin—Breast disorder—Doxorubicin—muscle cancer	0.00278	0.00535	CcSEcCtD
Mianserin—SLC6A2—testis—muscle cancer	0.00278	0.0125	CbGeAlD
Mianserin—HTR7—head—muscle cancer	0.00277	0.0125	CbGeAlD
Mianserin—ADRA2C—vagina—muscle cancer	0.00276	0.0124	CbGeAlD
Mianserin—Drowsiness—Methotrexate—muscle cancer	0.00274	0.00527	CcSEcCtD
Mianserin—Hypotension—Etoposide—muscle cancer	0.00273	0.00524	CcSEcCtD
Mianserin—ADRA2A—cardiac atrium—muscle cancer	0.00272	0.0123	CbGeAlD
Mianserin—HTR2A—smooth muscle tissue—muscle cancer	0.00268	0.0121	CbGeAlD
Mianserin—HTR7—testis—muscle cancer	0.00268	0.0121	CbGeAlD
Mianserin—Paraesthesia—Etoposide—muscle cancer	0.00262	0.00504	CcSEcCtD
Mianserin—DRD2—head—muscle cancer	0.00262	0.0118	CbGeAlD
Mianserin—Somnolence—Etoposide—muscle cancer	0.0026	0.00499	CcSEcCtD
Mianserin—Hepatobiliary disease—Methotrexate—muscle cancer	0.00259	0.00498	CcSEcCtD
Mianserin—Asthenia—Vincristine—muscle cancer	0.00259	0.00497	CcSEcCtD
Mianserin—HTR2A—renal system—muscle cancer	0.00258	0.0116	CbGeAlD
Mianserin—Agranulocytosis—Methotrexate—muscle cancer	0.00256	0.00492	CcSEcCtD
Mianserin—ADRA2C—head—muscle cancer	0.00255	0.0115	CbGeAlD
Mianserin—Rash—Dactinomycin—muscle cancer	0.00254	0.00489	CcSEcCtD
Mianserin—DRD2—testis—muscle cancer	0.00253	0.0114	CbGeAlD
Mianserin—Pancytopenia—Doxorubicin—muscle cancer	0.00253	0.00486	CcSEcCtD
Mianserin—Gastrointestinal disorder—Etoposide—muscle cancer	0.00252	0.00484	CcSEcCtD
Mianserin—Fatigue—Etoposide—muscle cancer	0.00252	0.00484	CcSEcCtD
Mianserin—Constipation—Etoposide—muscle cancer	0.0025	0.0048	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—muscle cancer	0.00249	0.00478	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—muscle cancer	0.00246	0.00473	CcSEcCtD
Mianserin—ADRA2C—testis—muscle cancer	0.00246	0.0111	CbGeAlD
Mianserin—Weight increased—Doxorubicin—muscle cancer	0.00242	0.00466	CcSEcCtD
Mianserin—HRH1—tendon—muscle cancer	0.00241	0.0109	CbGeAlD
Mianserin—Feeling abnormal—Etoposide—muscle cancer	0.00241	0.00462	CcSEcCtD
Mianserin—CYP3A4—renal system—muscle cancer	0.00239	0.0108	CbGeAlD
Mianserin—Dizziness—Vincristine—muscle cancer	0.00238	0.00458	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—muscle cancer	0.00237	0.00456	CcSEcCtD
Mianserin—ADRA2A—tendon—muscle cancer	0.00237	0.0107	CbGeAlD
Mianserin—CYP2D6—renal system—muscle cancer	0.00235	0.0106	CbGeAlD
Mianserin—Jaundice—Doxorubicin—muscle cancer	0.00231	0.00445	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—muscle cancer	0.0023	0.00442	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—muscle cancer	0.00229	0.00441	CcSEcCtD
Mianserin—CYP2B6—vagina—muscle cancer	0.00229	0.0103	CbGeAlD
Mianserin—Cardiac disorder—Methotrexate—muscle cancer	0.00228	0.00439	CcSEcCtD
Mianserin—Rash—Vincristine—muscle cancer	0.00227	0.00437	CcSEcCtD
Mianserin—Dermatitis—Vincristine—muscle cancer	0.00227	0.00436	CcSEcCtD
Mianserin—Headache—Vincristine—muscle cancer	0.00226	0.00434	CcSEcCtD
Mianserin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00225	0.00431	CcSEcCtD
Mianserin—HRH1—vagina—muscle cancer	0.00224	0.0101	CbGeAlD
Mianserin—Angiopathy—Methotrexate—muscle cancer	0.00223	0.00429	CcSEcCtD
Mianserin—Mediastinal disorder—Methotrexate—muscle cancer	0.00222	0.00426	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—muscle cancer	0.00222	0.00426	CcSEcCtD
Mianserin—ADRA2A—vagina—muscle cancer	0.0022	0.00992	CbGeAlD
Mianserin—Bradycardia—Doxorubicin—muscle cancer	0.00217	0.00417	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—muscle cancer	0.00216	0.00414	CcSEcCtD
Mianserin—Hepatitis—Doxorubicin—muscle cancer	0.00213	0.0041	CcSEcCtD
Mianserin—CYP2B6—head—muscle cancer	0.00212	0.00955	CbGeAlD
Mianserin—Asthenia—Etoposide—muscle cancer	0.00209	0.00403	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—muscle cancer	0.00209	0.00402	CcSEcCtD
Mianserin—HRH1—head—muscle cancer	0.00207	0.00932	CbGeAlD
Mianserin—Pruritus—Etoposide—muscle cancer	0.00207	0.00397	CcSEcCtD
Mianserin—CYP2B6—testis—muscle cancer	0.00205	0.00922	CbGeAlD
Mianserin—ADRA2A—head—muscle cancer	0.00203	0.00916	CbGeAlD
Mianserin—HTR2A—tendon—muscle cancer	0.00202	0.00909	CbGeAlD
Mianserin—HRH1—testis—muscle cancer	0.002	0.00901	CbGeAlD
Mianserin—Eye disorder—Doxorubicin—muscle cancer	0.00199	0.00383	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—muscle cancer	0.00199	0.00382	CcSEcCtD
Mianserin—Anaemia—Methotrexate—muscle cancer	0.00198	0.00381	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—muscle cancer	0.00198	0.0038	CcSEcCtD
Mianserin—ADRA2A—testis—muscle cancer	0.00196	0.00885	CbGeAlD
Mianserin—Angiopathy—Doxorubicin—muscle cancer	0.00193	0.00372	CcSEcCtD
Mianserin—Dizziness—Etoposide—muscle cancer	0.00193	0.00371	CcSEcCtD
Mianserin—Vertigo—Methotrexate—muscle cancer	0.00192	0.0037	CcSEcCtD
Mianserin—Mediastinal disorder—Doxorubicin—muscle cancer	0.00192	0.00369	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—muscle cancer	0.00192	0.00369	CcSEcCtD
Mianserin—HTR2A—vagina—muscle cancer	0.00187	0.00843	CbGeAlD
Mianserin—Mental disorder—Doxorubicin—muscle cancer	0.00187	0.00359	CcSEcCtD
Mianserin—Convulsion—Methotrexate—muscle cancer	0.00186	0.00357	CcSEcCtD
Mianserin—Rash—Etoposide—muscle cancer	0.00184	0.00354	CcSEcCtD
Mianserin—Dermatitis—Etoposide—muscle cancer	0.00184	0.00353	CcSEcCtD
Mianserin—Headache—Etoposide—muscle cancer	0.00183	0.00351	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—muscle cancer	0.00182	0.00351	CcSEcCtD
Mianserin—Myalgia—Methotrexate—muscle cancer	0.00182	0.00351	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00181	0.00348	CcSEcCtD
Mianserin—Confusional state—Methotrexate—muscle cancer	0.00176	0.00339	CcSEcCtD
Mianserin—HTR2A—head—muscle cancer	0.00173	0.00779	CbGeAlD
Mianserin—Nervous system disorder—Methotrexate—muscle cancer	0.00171	0.0033	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—muscle cancer	0.00171	0.0033	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—muscle cancer	0.00171	0.00329	CcSEcCtD
Mianserin—Agitation—Doxorubicin—muscle cancer	0.0017	0.00328	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—muscle cancer	0.0017	0.00326	CcSEcCtD
Mianserin—HTR2A—testis—muscle cancer	0.00167	0.00752	CbGeAlD
Mianserin—Vertigo—Doxorubicin—muscle cancer	0.00167	0.0032	CcSEcCtD
Mianserin—Syncope—Doxorubicin—muscle cancer	0.00166	0.0032	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—muscle cancer	0.00166	0.00319	CcSEcCtD
Mianserin—Hypotension—Methotrexate—muscle cancer	0.00163	0.00314	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—muscle cancer	0.00163	0.00313	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—muscle cancer	0.00161	0.00309	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—muscle cancer	0.0016	0.00308	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00159	0.00306	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—muscle cancer	0.00158	0.00304	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—muscle cancer	0.00158	0.00304	CcSEcCtD
Mianserin—CYP2D6—head—muscle cancer	0.00157	0.00709	CbGeAlD
Mianserin—Paraesthesia—Methotrexate—muscle cancer	0.00157	0.00302	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00157	0.00301	CcSEcCtD
Mianserin—Somnolence—Methotrexate—muscle cancer	0.00155	0.00299	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—muscle cancer	0.00154	0.00297	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—muscle cancer	0.00153	0.00293	CcSEcCtD
Mianserin—CYP2D6—testis—muscle cancer	0.00152	0.00685	CbGeAlD
Mianserin—Oedema—Doxorubicin—muscle cancer	0.00151	0.00291	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00151	0.0029	CcSEcCtD
Mianserin—Fatigue—Methotrexate—muscle cancer	0.00151	0.0029	CcSEcCtD
Mianserin—Shock—Doxorubicin—muscle cancer	0.00149	0.00286	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—muscle cancer	0.00148	0.00285	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00148	0.00285	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—muscle cancer	0.00148	0.00284	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—muscle cancer	0.00147	0.00283	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—muscle cancer	0.00144	0.00277	CcSEcCtD
Mianserin—Hypotension—Doxorubicin—muscle cancer	0.00141	0.00272	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00138	0.00265	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—muscle cancer	0.00136	0.00261	CcSEcCtD
Mianserin—Somnolence—Doxorubicin—muscle cancer	0.00135	0.00259	CcSEcCtD
Mianserin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00131	0.00251	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—muscle cancer	0.00131	0.00251	CcSEcCtD
Mianserin—Constipation—Doxorubicin—muscle cancer	0.00129	0.00249	CcSEcCtD
Mianserin—Asthenia—Methotrexate—muscle cancer	0.00125	0.00241	CcSEcCtD
Mianserin—Feeling abnormal—Doxorubicin—muscle cancer	0.00125	0.0024	CcSEcCtD
Mianserin—Pruritus—Methotrexate—muscle cancer	0.00124	0.00238	CcSEcCtD
Mianserin—Dizziness—Methotrexate—muscle cancer	0.00116	0.00222	CcSEcCtD
Mianserin—Rash—Methotrexate—muscle cancer	0.0011	0.00212	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—muscle cancer	0.0011	0.00212	CcSEcCtD
Mianserin—Headache—Methotrexate—muscle cancer	0.0011	0.00211	CcSEcCtD
Mianserin—Asthenia—Doxorubicin—muscle cancer	0.00109	0.00209	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—muscle cancer	0.00107	0.00206	CcSEcCtD
Mianserin—Dizziness—Doxorubicin—muscle cancer	0.001	0.00192	CcSEcCtD
Mianserin—Rash—Doxorubicin—muscle cancer	0.000955	0.00183	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—muscle cancer	0.000954	0.00183	CcSEcCtD
Mianserin—Headache—Doxorubicin—muscle cancer	0.000949	0.00182	CcSEcCtD
